Citation:Buttar NS, Wang KK, Sebo TJ, Riehle DM, Krishnadath KK, Lutzke LS, et al 2001

From Clinical Guidelines Wiki

Citation


Buttar NS, Wang KK, Sebo TJ, Riehle DM, Krishnadath KK, Lutzke LS, et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001 Jun 1 [cited 32202 Jan 1];120(7):1630-9 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/11375945.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?Professor David Whiteman B Med Sci, MBBS (Hons) PhD FAFPHMcompleted
Are there groups of patients with non-dysplastic BO that require more frequent surveillance?Dr Henry Tocompleted
Are there groups of patients with BO that can be discharged from surveillance?Conjoint Associate Professor Philip Craigcompleted

Compare quality appraisals for each clinical question

Cited by

  1. What endoscopic surveillance protocol should be followed for patients with BO and high grade dysplasia?